| First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer L Horn, AS Mansfield, A Szczęsna, L Havel, M Krzakowski, MJ Hochmair, ... New England Journal of Medicine 379 (23), 2220-2229, 2018 | 2720 | 2018 |
| CD24: a novel target for cancer immunotherapy E Panagiotou, NK Syrigos, A Charpidou, E Kotteas, IA Vathiotis Journal of Personalized Medicine 12 (8), 1235, 2022 | 37 | 2022 |
| Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry T MacNeil, IA Vathiotis, S Martinez-Morilla, V Yaghoobi, J Zugazagoitia, ... Biotechniques 69 (6), 460-468, 2020 | 34 | 2020 |
| A new tool for technical standardization of the Ki67 immunohistochemical assay TN Aung, B Acs, J Warrell, Y Bai, P Gaule, S Martinez-Morilla, I Vathiotis, ... Modern Pathology 34 (7), 1261-1270, 2021 | 31 | 2021 |
| Tumor dormancy: implications for invasion and metastasis G Gomatou, N Syrigos, IA Vathiotis, EA Kotteas International journal of molecular sciences 22 (9), 4862, 2021 | 29 | 2021 |
| Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer MK Moutafi, W Tao, R Huang, J Haberberger, B Alexander, S Ramkissoon, ... Journal for immunotherapy of cancer 9 (4), 2021 | 29 | 2021 |
| Targeting pyruvate kinase M2 phosphorylation reverses aggressive cancer phenotypes M Apostolidi, IA Vathiotis, V Muthusamy, P Gaule, BM Gassaway, ... Cancer research 81 (16), 4346-4359, 2021 | 28 | 2021 |
| Khorana score: νew predictor of early mortality in patients with lung adenocarcinoma I Vathiotis, EP Dimakakos, P Boura, A Ntineri, A Charpidou, G Gerotziafas, ... Clinical and Applied Thrombosis/Hemostasis 24 (8), 1347-1351, 2018 | 27 | 2018 |
| The role of tinzaparin in oncology EP Dimakakos, I Vathiotis, K Syrigos Clinical and Applied Thrombosis/Hemostasis 24 (5), 697-707, 2018 | 24 | 2018 |
| H1N1-induced venous thromboembolic events? Results of a single-institution case series E Dimakakos, D Grapsa, I Vathiotis, A Papaspiliou, M Panagiotarakou, ... Open forum infectious diseases 3 (4), ofw214, 2016 | 22 | 2016 |
| Discovery of biomarkers of resistance to immune checkpoint blockade in NSCLC using high-plex digital spatial profiling M Moutafi, S Martinez-Morilla, P Divakar, I Vathiotis, N Gavrielatou, ... Journal of Thoracic Oncology 17 (8), 991-1001, 2022 | 18 | 2022 |
| Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer MK Moutafi, M Molero, SM Morilla, J Baena, IA Vathiotis, N Gavrielatou, ... Journal for immunotherapy of cancer 10 (8), 2022 | 18 | 2022 |
| Association of PD-1/PD-L1 co-location with immunotherapy outcomes in non–small cell lung cancer N Gavrielatou, Y Liu, I Vathiotis, J Zugazagoitia, TN Aung, S Shafi, ... Clinical Cancer Research 28 (2), 360-367, 2022 | 17 | 2022 |
| Enhancing programmed cell death protein 1 axis inhibition in head and neck squamous cell carcinoma: Combination immunotherapy IA Vathiotis, JM Johnson, A Argiris Cancer Treatment Reviews 97, 102192, 2021 | 16 | 2021 |
| Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms TN Aung, S Shafi, JS Wilmott, S Nourmohammadi, I Vathiotis, ... EBioMedicine 82, 2022 | 15 | 2022 |
| Alpha-smooth muscle actin expression in the stroma predicts resistance to trastuzumab in patients with early-stage HER2-positive breast cancer IA Vathiotis, MK Moutafi, P Divakar, TN Aung, T Qing, A Fernandez, ... Clinical Cancer Research 27 (22), 6156-6163, 2021 | 13 | 2021 |
| HER2 aberrations in non-small cell lung cancer: From pathophysiology to targeted therapy IA Vathiotis, A Charpidou, N Gavrielatou, KN Syrigos Pharmaceuticals 14 (12), 1300, 2021 | 12 | 2021 |
| Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event N Syrigos, A Kollias, D Grapsa, E Fyta, KG Kyriakoulis, I Vathiotis, ... Vaccines 10 (5), 745, 2022 | 11 | 2022 |
| Programmed death-ligand 1 as a regulator of tumor progression and metastasis IA Vathiotis, G Gomatou, DJ Stravopodis, N Syrigos International Journal of Molecular Sciences 22 (10), 5383, 2021 | 11 | 2021 |
| Vaccine-related autoimmune hepatitis: emerging association with SARS-CoV-2 vaccination or coincidence? IP Trontzas, KG Kyriakoulis, IA Vathiotis, A Syrigos, G Kounadis, ... Vaccines 10 (12), 2073, 2022 | 10 | 2022 |
